GLOBAL ONCOLOGY INTELLIGENCE

Connecting Oncology through data

Unravel the complexities of cancer treatment with patient-level data-driven solutions.

Our mission is to advance the fight against cancer by providing real-world clinical insights and data-driven solutions to Life Sciences companies, cancer researchers, and healthcare professionals. 

GLOBAL ONCOLOGY INTELLIGENCE VIDEO
​Oncology Dynamics
Iqvia Human data science

Make confident data-driven decisions

IQVIA delivers oncology data assets from a stable and representative panel of physicians to give you a competitive edge in the rapidly evolving oncology landscape.

  • Easily access rich, structured, multi-country, anonymous patient-level data
  • Compare KPIs across tumor types, drugs, and countries through consistent methodology
  • Derive insights and understand trends in cancer care
  • Compare biomarker testing rates
  • Available in more than 20 countries globally

Get the insights you need to gain competitive advantage

IQVIA Global Oncology Intelligence provides you with the latest insights on cancer treatments, market dynamics, and clinical practice to make informed decisions.

Access harmonized data and treatment insights to understand global trends in cancer care and stay ahead of the competition.

WEBINAR

Oncology Precision Medicine Landscape

Join us as we explore the evolving landscape of precision medicine and biomarker testing and its impact on oncology markets across different tumor types and geographies.

Wednesday, July 10, 2024

ON DEMAND WEBINAR

Oncology Launch Excellence

Join IQVIA in its Launch Excellence web-series where we share key trends impacting oncology launches, explore factors driving successful commercial models for new oncology launches, and share learnings from an industry expert.

Wednesday, June 19, 2024

SPEAK WITH AN EXPERT
Find out more about our Global Oncology Intelligence Solutions
Want more information? Schedule a time with one of our team members to hear about how you can leverage latest insights on cancer treatments, market dynamics, and clinical practices.

2024 ASCO Annual Meeting: Abstract

Explore IQVIA experts research, as discussed at ASCO 2024: Usage pattern of anticoagulants in oncology patients receiving active anticancer therapies in Europe and Asia.

IQVIA's Recent Journal Publication on Acute Myeloid Leukemia

We now have new treatments for patients suffering from a type of blood cancer called acute myeloid leukemia (acronym AML). They are available as the first choice of therapy. In this study we explored how these new treatments are included in daily patient care.

Related Solutions

Contact Us